Literature DB >> 16631614

Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation.

Zhihui Liu1, Xuezhong Yang, Fei Tan, Kathleen Cullion, Carol J Thiele.   

Abstract

Castor is a zinc finger transcription factor that controls cell fate within neuroblast cell lineages in Drosophila melanogaster. Here, we describe the cloning and characterization of a human castor gene (CASZ1) that is structurally homologous to Drosophila castor. We find the expression of castor gene is increased when cells of neural origin as well as mesenchymal origin are induced to differentiation. CASZ1 is expressed in a number of normal tissues and exists in at least two mRNA species of 4.4 and 8.0kb. They are named hCasz5 and hCasz11 because the predicted proteins have 5 and 11 zinc fingers, respectively. Deletion analysis of the proximal 5'-flanking sequences delineates sequences sufficient to drive transcription in cells of neural and non-neural origin. Both hCasz5 and hCasz11 localize predominantly in the nucleus, consistent with their role as Zn-finger containing transcription factor. CASZ1 is expressed in a number of human tumors and localizes to a chromosomal region frequently lost in tumors of neuroectodermal origin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631614     DOI: 10.1016/j.bbrc.2006.03.207

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.

Authors:  Chunxi Wang; Zhihui Liu; Chan-Wook Woo; Zhijie Li; Lifeng Wang; Jun S Wei; Victor E Marquez; Susan E Bates; Qihuang Jin; Javed Khan; Kai Ge; Carol J Thiele
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

Review 2.  Therapeutic targets for neuroblastomas.

Authors:  Garrett M Brodeur; Radhika Iyer; Jamie L Croucher; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

3.  CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity.

Authors:  Zhihui Liu; Julieann Rader; Stanley He; Tanya Phung; Carol J Thiele
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

4.  Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study.

Authors:  Jennifer E Ho; Daniel Levy; Lynda Rose; Andrew D Johnson; Paul M Ridker; Daniel I Chasman
Journal:  J Hypertens       Date:  2011-01       Impact factor: 4.844

5.  Differential regulation of CASZ1 protein expression during cardiac and skeletal muscle development.

Authors:  Nirav M Amin; Devin Gibbs; Frank L Conlon
Journal:  Dev Dyn       Date:  2014-05-29       Impact factor: 3.780

Review 6.  Zinc and Zinc Transporters: Novel Regulators of Ventricular Myocardial Development.

Authors:  Wen Lin; Deqiang Li
Journal:  Pediatr Cardiol       Date:  2018-03-13       Impact factor: 1.655

Review 7.  The CASZ1/Egfl7 transcriptional pathway is required for RhoA expression in vascular endothelial cells.

Authors:  Marta S Charpentier; Joan M Taylor; Frank L Conlon
Journal:  Small GTPases       Date:  2013-10-22

8.  CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.

Authors:  Z Liu; X Yang; Z Li; C McMahon; C Sizer; L Barenboim-Stapleton; V Bliskovsky; B Mock; T Ried; W B London; J Maris; J Khan; C J Thiele
Journal:  Cell Death Differ       Date:  2011-01-21       Impact factor: 15.828

9.  Congenital heart disease protein 5 associates with CASZ1 to maintain myocardial tissue integrity.

Authors:  Stephen Sojka; Nirav M Amin; Devin Gibbs; Kathleen S Christine; Marta S Charpentier; Frank L Conlon
Journal:  Development       Date:  2014-07-03       Impact factor: 6.868

10.  Vertebrate CASTOR is required for differentiation of cardiac precursor cells at the ventral midline.

Authors:  Kathleen S Christine; Frank L Conlon
Journal:  Dev Cell       Date:  2008-04       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.